Product
Flu-Bu-Mel
1 clinical trial
1 indication
Indication
Relapse Rate After Allo-HSCTClinical trial
Phase II Study ofFlu-Bu-Mel Conditioning Regimen for Patients With Myeloid Disease Undergoing Allogeneic Stem Cell TransplantationStatus: Completed, Estimated PCD: 2023-03-30